This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Catastrophic antiphospholipid syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Catastrophic antiphospholipid syndrome (CAPS) is a rare life-threatening cause of multi-organ failure with an acute onset (1).

  • observed in less than 1% of APS patients (2)
  • it is characterized by the development of microthrombi in multiple small vascular beds in several organ systems leading to multioragn failure e.g. - typically the brain, kidneys, lung and the skin

Important differential diagnosis include -thrombotic thrombocytopaenic purpura, haemolytic uraemic syndrome, and disseminated intravascular coagulation (2)

Combinations of treatment are typically used including anticoagulation with heparin/warfarin. In addition Immunomodulatory therapies including plasmaphaeresis, intravenous human IgG, corticosteroids and rituximab have been employed (1).

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.